ATRECA INC's ticker is BCEL and the CUSIP is 04965G109. A total of 107 filers reported holding ATRECA INC in Q3 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,992 | -73.4% | 22,959 | 0.0% | 0.00% | – |
| Q2 2023 | $22,500 | -14.0% | 22,959 | 0.0% | 0.00% | – |
| Q1 2023 | $26,173 | -88.4% | 22,959 | -67.5% | 0.00% | – |
| Q1 2022 | $225,000 | +11.9% | 70,719 | +6.8% | 0.00% | – |
| Q4 2021 | $201,000 | -51.3% | 66,197 | 0.0% | 0.00% | – |
| Q3 2021 | $413,000 | -26.8% | 66,197 | 0.0% | 0.00% | – |
| Q2 2021 | $564,000 | -49.6% | 66,197 | -9.3% | 0.00% | – |
| Q1 2021 | $1,119,000 | -2.6% | 72,952 | +2.6% | 0.00% | – |
| Q4 2020 | $1,149,000 | +18.1% | 71,132 | +2.2% | 0.00% | – |
| Q3 2020 | $973,000 | -7.9% | 69,604 | +40.3% | 0.00% | -100.0% |
| Q2 2020 | $1,056,000 | +74.8% | 49,624 | +36.1% | 0.00% | – |
| Q1 2020 | $604,000 | +183.6% | 36,468 | +165.4% | 0.00% | – |
| Q4 2019 | $213,000 | +26.0% | 13,743 | 0.0% | 0.00% | – |
| Q3 2019 | $169,000 | – | 13,743 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copernicus Capital Management, LLC | 18,000 | $276,000 | 4.46% |
| Bill & Melinda Gates Foundation | 1,396,644 | $21,411,000 | 3.50% |
| EcoR1 Capital, LLC | 2,426,685 | $37,201,000 | 1.65% |
| Boxer Capital, LLC | 2,202,333 | $33,762,000 | 1.14% |
| Samsara BioCapital, LLC | 396,835 | $6,083,000 | 1.12% |
| Aisling Capital Management LP | 387,653 | $5,943,000 | 1.07% |
| CM Management, LLC | 60,000 | $920,000 | 0.68% |
| Parkman Healthcare Partners LLC | 151,993 | $2,330,000 | 0.54% |
| Redmile Group, LLC | 2,490,568 | $38,180,000 | 0.54% |
| HighVista Strategies LLC | 34,301 | $526,000 | 0.39% |